BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 36308562)

  • 1. Respiratory effects of oral mitragynine and oxycodone in a rodent model.
    Henningfield JE; Rodricks JV; Magnuson AM; Huestis MA
    Psychopharmacology (Berl); 2022 Dec; 239(12):3793-3804. PubMed ID: 36308562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of Mitragyna speciosa extract, mitragynine, and opioid agonists on thermal nociception in rats.
    Carpenter JM; Criddle CA; Craig HK; Ali Z; Zhang Z; Khan IA; Sufka KJ
    Fitoterapia; 2016 Mar; 109():87-90. PubMed ID: 26688378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Pharmacokinetics of Mitragynine after Oral Administration of Mitragyna speciosa (Kratom) Leaf Extracts in Rats.
    Avery BA; Boddu SP; Sharma A; Furr EB; Leon F; Cutler SJ; McCurdy CR
    Planta Med; 2019 Mar; 85(4):340-346. PubMed ID: 30452072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of mitragynine and morphine on schedule-controlled responding and antinociception in rats.
    Hiranita T; Leon F; Felix JS; Restrepo LF; Reeves ME; Pennington AE; Obeng S; Avery BA; McCurdy CR; McMahon LR; Wilkerson JL
    Psychopharmacology (Berl); 2019 Sep; 236(9):2725-2734. PubMed ID: 31098655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kratom Alkaloids, Natural and Semi-Synthetic, Show Less Physical Dependence and Ameliorate Opioid Withdrawal.
    Wilson LL; Chakraborty S; Eans SO; Cirino TJ; Stacy HM; Simons CA; Uprety R; Majumdar S; McLaughlin JP
    Cell Mol Neurobiol; 2021 Jul; 41(5):1131-1143. PubMed ID: 33433723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators.
    Kruegel AC; Gassaway MM; Kapoor A; Váradi A; Majumdar S; Filizola M; Javitch JA; Sames D
    J Am Chem Soc; 2016 Jun; 138(21):6754-64. PubMed ID: 27192616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions.
    Todd DA; Kellogg JJ; Wallace ED; Khin M; Flores-Bocanegra L; Tanna RS; McIntosh S; Raja HA; Graf TN; Hemby SE; Paine MF; Oberlies NH; Cech NB
    Sci Rep; 2020 Nov; 10(1):19158. PubMed ID: 33154449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The respiratory depressant effects of mitragynine are limited by its conversion to 7-OH mitragynine.
    Hill R; Kruegel AC; Javitch JA; Lane JR; Canals M
    Br J Pharmacol; 2022 Jul; 179(14):3875-3885. PubMed ID: 35297034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of mitragynine in man.
    Trakulsrichai S; Sathirakul K; Auparakkitanon S; Krongvorakul J; Sueajai J; Noumjad N; Sukasem C; Wananukul W
    Drug Des Devel Ther; 2015; 9():2421-9. PubMed ID: 25995615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitragyna speciosa, a psychoactive tree from Southeast Asia with opioid activity.
    Adkins JE; Boyer EW; McCurdy CR
    Curr Top Med Chem; 2011; 11(9):1165-75. PubMed ID: 21050173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-2.
    Váradi A; Marrone GF; Palmer TC; Narayan A; Szabó MR; Le Rouzic V; Grinnell SG; Subrath JJ; Warner E; Kalra S; Hunkele A; Pagirsky J; Eans SO; Medina JM; Xu J; Pan YX; Borics A; Pasternak GW; McLaughlin JP; Majumdar S
    J Med Chem; 2016 Sep; 59(18):8381-97. PubMed ID: 27556704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Mitragynine and 7-Hydroxymitragynine Pharmacokinetics after Single and Multiple Daily Doses of Oral Encapsulated Dried Kratom Leaf Powder.
    Huestis MA; Brett MA; Bothmer J; Atallah R
    Molecules; 2024 Feb; 29(5):. PubMed ID: 38474495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic effects of main indole alkaloid of kratom, mitragynine in acute pain animal model.
    Mat NH; Bakar SNS; Murugaiyah V; Chawarski MC; Hassan Z
    Behav Brain Res; 2023 Feb; 439():114251. PubMed ID: 36503042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kratom policy: The challenge of balancing therapeutic potential with public safety.
    Prozialeck WC; Avery BA; Boyer EW; Grundmann O; Henningfield JE; Kruegel AC; McMahon LR; McCurdy CR; Swogger MT; Veltri CA; Singh D
    Int J Drug Policy; 2019 Aug; 70():70-77. PubMed ID: 31103778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and Safety of Mitragynine in Beagle Dogs.
    Maxwell EA; King TI; Kamble SH; Raju KSR; Berthold EC; León F; Avery BA; McMahon LR; McCurdy CR; Sharma A
    Planta Med; 2020 Nov; 86(17):1278-1285. PubMed ID: 32693425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the rewarding effects of mitragynine and 7-hydroxymitragynine in an intracranial self-stimulation procedure in male and female rats.
    Behnood-Rod A; Chellian R; Wilson R; Hiranita T; Sharma A; Leon F; McCurdy CR; McMahon LR; Bruijnzeel AW
    Drug Alcohol Depend; 2020 Oct; 215():108235. PubMed ID: 32889450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of mitragynine, the principle alkaloid of Mitragyna speciosa: present knowledge and future directions in perspective of pain.
    Ramachandram DS; Damodaran T; Zainal H; Murugaiyah V; Ramanathan S
    J Basic Clin Physiol Pharmacol; 2019 Oct; 31(1):. PubMed ID: 31665120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactive Effects of
    Obeng S; Leon F; Patel A; Zuarth Gonzalez JD; Chaves Da Silva L; Restrepo LF; Gamez-Jimenez LR; Ho NP; Guerrero Calvache MP; Pallares VLC; Helmes JA; Shiomitsu SK; Soto PL; McCurdy CR; McMahon LR; Wilkerson JL; Hiranita T
    J Pharmacol Exp Ther; 2022 Dec; 383(3):182-198. PubMed ID: 36153006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of Eleven Kratom Alkaloids Following an Oral Dose of Either Traditional or Commercial Kratom Products in Rats.
    Kamble SH; Berthold EC; King TI; Raju Kanumuri SR; Popa R; Herting JR; León F; Sharma A; McMahon LR; Avery BA; McCurdy CR
    J Nat Prod; 2021 Apr; 84(4):1104-1112. PubMed ID: 33620222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurobiology of Kratom and its main alkaloid mitragynine.
    Suhaimi FW; Yusoff NH; Hassan R; Mansor SM; Navaratnam V; Müller CP; Hassan Z
    Brain Res Bull; 2016 Sep; 126(Pt 1):29-40. PubMed ID: 27018165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.